I suspect the market is pricing in first mover advantage in China with the MIGS iTrack. Its actually a very big deal what they have pulled off and the Chinese market will be the biggest in the world in a few years.
ELX has a very diverse product range in a growing market with competitive advantage in China and the wild card 2RT thrown in as a sweetener for investors. Its now a real success story , about the only one in Adelaide right now I suspect!
This is as good as it gets for an investor in the health sector.
I sold off 10% of my holding when it was hitting 160 but will sit on the rest for a few years unless something untoward happens
Ann: Ellex iTrack commencement of clincal training in China, page-16
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $62.92M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $105.1K | 377.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99735 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 39325 | 2 |
View Market Depth
| Last trade - 15.59pm 16/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |